We are Sorry, This Page doesn't Exist
Alligator Bioscience AB: Year-end Report January-December 2020
STOCKHOLM, Feb. 26, 2021 /PRNewswire/ -- "Safety data has been presented from the ongoing Phase I study with ATOR-1017 in patients with metastatic cancer. The results show a promising safety profile w.....»»
Kodiak Sciences announces safety, efficacy from Phase 1b study of KSI-301
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Kodiak Sciences announces emerging durability data from Phase 1 study of KSI-301
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Akari Therapeutics Reports Second Quarter 2019 Financial Results And Highlights Recent Clinical Progress
- Positive early safety and efficacy data with nomacopan Phase II clinical study in patients with mild-to-moderate bullous pemph.....»»
Aptevo Therapeutics Reports Second Quarter 2019 Financial Results
Reports Positive Preliminary Top-Line Safety Data for APVO210Phase 1 Single Ascending Dose (SAD) Clinical Study Advances APVO210 into Phase 1 Multiple Ascending Dose (MAD) Study Co.....»»
Kodiak Sciences announces interim data from ongoing Phase 1B study of KSI-301
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Myovant Sciences Provides Corporate Updates and Reports Financial Results for Fourth Fiscal Quarter and Full Fiscal Year Ended March 31, 2019
-Announced positive Phase 3 results from LIBERTY 1 study evaluating relugolix combination therapy in women with uterine fibroids- -Data from four additional Phase 3 clinical studies ex.....»»
Wave Life Sciences Plunges After DMD Study Data Readout
Wave Life Sciences (WVE) announces final safety data from a phase I DMD study evaluating suvodirsen and provides design update for phase II/III stage developm.....»»
Enliven Therapeutics Shares First Look At Safety, Clinical Activity Of Lead Program
Enliven Therapeutics' Phase 1 trial results for ELVN-001 in chronic myeloid leukemia (CML) patients. Explore the promising safety and efficacy data. read more.....»»
Aptinyx reports "positive" data from Phase 2 study of NYX-783
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
AIM ImmunoTech announces safety data from Phase 1 study of Ampligen
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Turning Point reports Phase 1/2 SWORD-1 study data of TPX-0046
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Krystal Biotech launches Jeune subsidiary, reports Phase 1 safety data for KB301
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
BrainStorm reports "positive" data in Phase 2 study evaluating NurOwn
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Epizyme reports preliminary data from Phase 1b/3 study of EZH-302
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Epizyme reports preliminary data from Phase 1b/2 study of EZH-1101
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Denali Therapeutics reports three-month data from Phase 1/2 study of ETV:IDS
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Tiziana Life Sciences reports data from Foralumab study in COVID-19 patients
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Seneca Biopharma reports data from Phase 2 study of NSI-566 in China
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
RedHill Biopharma announces safety, efficacy data from Phase 2 COVID-19 study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»